Related Experiment Videos
HLA-DRB1 matched kidneys are preferentially HLA-A and -B compatible and survive longer
D E Speiser1, M Jeannet, C Goumaz
1National Reference Laboratory for Histocompatibility, Hôpital Cantonal Universitaire de Genève, Switzerland.
Insights
Precise HLA-DRB1 matching using DNA typing, not serology, significantly improved kidney transplant graft survival. This enhanced matching also led to better HLA-A and -B compatibility, suggesting improved MHC matching strategies.
Area of Science:
- Immunogenetics
- Transplantation immunology
Background:
- Human Leukocyte Antigen (HLA) matching is crucial for kidney transplant success.
- Conventional serological typing for HLA-DR may lack the resolution needed for optimal matching.
Purpose of the Study:
- To compare HLA-DR serology with DNA-based oligotyping for DRB1 matching in kidney transplantation.
- To evaluate the impact of different HLA-DR matching strategies on graft survival and broader Major Histocompatibility Complex (MHC) matching.
Main Methods:
- Analysis of 111 cadaveric donors and 156 kidney recipients.
- Comparison of conventional DR serology with PCR-amplified DRB1 exon 2 DNA oligotyping.
- Assessment of graft survival at 2.5 years based on matching strategies.
Main Results:
- Discrepancies between serology and DNA typing were observed in 10.1% of cases.
- Serology-based HLA-DR matching showed no significant difference in graft survival (0.87 vs 0.83).
- DRB1 oligotyping-based matching revealed a significant difference in graft survival (0.95 vs 0.82) and improved HLA-A and -B matching.
Conclusions:
- High-resolution DRB1 DNA typing offers superior precision for HLA matching in kidney transplantation compared to serology.
- Precise matching at the DRB1 locus positively influences matching at other MHC loci.
- Advancements in high-resolution typing techniques are essential for developing refined clinical matching strategies.
Abstract:
HLA-DR matching was analysed in 111 cadaveric donors and 156 patients who underwent kidney transplantation. We compared the results of conventional DR serology with sequence specific oligonucleotide typing performed on PCR-amplified DRB1 exon 2 DNA. We found discrepancies between serology and DNA typing in 10.1% when the broad antigen specificities DR1-10 were considered. The graft survival probability at 2.5 years between HLA-DR matched versus mismatched transplants was not different (0.87 vs 0.83) when matching was based on serology. However, a significant graft survival difference (0.95 vs 0.82) was found when matching was based on oligotyping for DRB1 (including all subtypes). Furthermore, a better matching for HLA-A and -B was found in the DRB1 matched group. Therefore, precise matching at one particular locus (as shown here for the DRB1 locus) significantly increases the chance to be matched at further MHC loci. The further development of high-resolution typing techniques for most or all HLA-A, -B, -C, -DR, -DQ, -DP antigens may in the future allow more precise definitions of clinically important mismatches helping to develop rational matching strategies.